AUTHOREA
Log in Sign Up Browse Preprints
LOG IN SIGN UP
Elisa Meucci
Elisa Meucci

Public Documents 2
Potential culprits for immediate hypersensitivity reactions to BNT162b2 mRNA COVID-19...
Anna Radice
Filippo Fassio

Anna Radice

and 4 more

March 30, 2022
Title:
Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito...
Elisa Meucci
Anna Radice

Elisa Meucci

and 4 more

June 28, 2021
Mosquito allergy can rarely give raise to severe clinical manifestations.Here we describe the case of a patient suffering from relapsing anaphylaxis after mosquito bites, who completely responded to off label therapy with anti-IgE monoclonal antibody.This is the first demonstration of the efficacy of omalizumab in such unusual life-threatening allergy.

| Powered by Authorea.com

  • Home